Flagship explainer
What drives EMERGENT BIOSOLUTIONS INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| $52.6M | FY2025 |
| |
| Income before tax | $82.8M | FY2025 |
|
| Operating income | $100M | FY2025 |
|
| $743M | FY2025 |
| |
| Ending assets | $1.3B | FY2025 |
|
| Beginning assets | $1.4B | FY2024 |
|
| $523M | FY2025 |
| |
| $483M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001367644-26-000015